US 10435399
HDAC6 inhibitory heterocyclic compound
granted A61PA61P25/28
Quick answer
US patent 10435399 (HDAC6 inhibitory heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Oct 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P25/28